Gemphire is a developer of novel drugs like gemcabene for the treatment of dyslipidemia patients... Read more
Gemphire is a developer of novel drugs like gemcabene for the treatment of dyslipidemia patients... Read more
News
Jan 13, 2020
Pharamceutical Technology
Gemphire Therapeutics: NeuroBo Pharmaceuticals complete Gemphire merger
Jan 10, 2020
BioSpace
Gemphire Therapeutics: NeuroBo Pharmaceuticals and Gemphire Therapeutics Complete Merger
Dec 31, 2019
Crain's Detroit Business
Gemphire Therapeutics: Drug maker Gemphire completes merger with NeuroBo
Dec 30, 2019
Benzinga
Gemphire Therapeutics: Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
Dec 24, 2019
BioPortfolio
Gemphire Therapeutics: Gemphire Therapeutics Inc GEMP Financial and Strategic SWOT Analysis Review Report Updated 10042019 Prices from USD $106
Dec 06, 2019
BioSpace
Gemphire Therapeutics: Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo Pharmaceuticals
Dec 06, 2019
FIRSTWORD PHARMA
Gemphire Therapeutics: Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo Pharmaceuticals
Aug 19, 2019
BioPortfolio
Gemphire Therapeutics: Gemphire Therapeutics Inc GEMP Financial and Strategic SWOT Analysis Review Published by Global Data Prices from USD $125
Aug 09, 2019
MarketScreener
Gemphire Therapeutics: Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 26, 2019
BioSpace
Gemphire Therapeutics: Privately-Held NeuroBo Enters Reverse-Merger Deal with Gemphire